{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T07:07:59Z","timestamp":1783667279263,"version":"3.55.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T00:00:00Z","timestamp":1721174400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T00:00:00Z","timestamp":1721174400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s00228-024-03716-3","type":"journal-article","created":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T00:02:16Z","timestamp":1721174536000},"page":"1593-1595","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["No evidence of clinical efficacy of oxomemazine in cough, according to a systematic review"],"prefix":"10.1007","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7566-9719","authenticated-orcid":false,"given":"Trystan","family":"Bacon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Blanchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estelle","family":"Dubois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Vaillant-Roussel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9my","family":"Boussageon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,17]]},"reference":[{"issue":"114","key":"3716_CR1","first-page":"148","volume":"25","author":"L Letrilliart","year":"2014","unstructured":"Letrilliart L, Supper I, Schuers M, Darmon D, Boulet P, Favre M et al (2014) ECOGEN: \u00e9tude des \u00e9l\u00e9ments de la consultation en m\u00e9decine g\u00e9n\u00e9rale. Exercer 25(114):148\u201357","journal-title":"Exercer"},{"key":"3716_CR2","doi-asserted-by":"publisher","unstructured":"Santo L, Kang K (2019) National Ambulatory Medical Care Survey: 2019 national summary tables. Natl Center Health Stat 41. Available from: https:\/\/doi.org\/10.15620\/cdc:123251","DOI":"10.15620\/cdc:123251"},{"key":"3716_CR3","unstructured":"Assurance Maladie (2023) M\u00e9dicaments d\u00e9livr\u00e9s par les pharmacies de ville par classe ATC - Medic\u2019AM - en cumul annuel 2022 (s\u00e9rie labellis\u00e9e). Available from: https:\/\/assurance-maladie.ameli.fr\/sites\/default\/files\/2022-medic-am-par-classe-atc_serie-annuelle-labellisee.zip"},{"key":"3716_CR4","unstructured":"AFSSAPS (2002) Toplexil 0,33mg\/ml, sirop. Agence fran\u00e7aise de s\u00e9curit\u00e9 sanitaire des produits de sant\u00e9 [cited 2023 May 8]. Available from: https:\/\/www.has-sante.fr\/upload\/docs\/application\/pdf\/ct031277.pdf"},{"key":"3716_CR5","unstructured":"Haute Autorit\u00e9 de Sant\u00e9 (2011) Toplexil 0,33 mg\/ml sans sucre, solution buvable \u00e9dulcor\u00e9e \u00e0 l\u2019ac\u00e9sulfame potassique et Toplexil 0,33 mg\/ml, sirop. Haute Autorit\u00e9 de Sant\u00e9 5. Available from: https:\/\/www.has-sante.fr\/upload\/docs\/application\/pdf\/2012-01\/toplexil_14_12_2011_avis_ct11358.pdf"},{"key":"3716_CR6","unstructured":"Haute Autorit\u00e9 de Sant\u00e9 (2021) Oxom\u00e9mazine Cristers 0,33 mg\/ml, sirop\u202f: mise \u00e0 disposition d\u2019une nouvelle pr\u00e9sentation. Haute Autorit\u00e9 de Sant\u00e9 4. Available from: https:\/\/www.has-sante.fr\/upload\/docs\/evamed\/CT-19177_OXOMEMAZINE_CRISTERS_PIS_INS_AvisDef_CT19177.pdf"},{"key":"3716_CR7","doi-asserted-by":"crossref","unstructured":"Haute Autorit\u00e9 de Sant\u00e9 (2008) Toplexil 0,33mg\/ml, sirop. Haute Autorit\u00e9 de Sant\u00e9 2. Available from: https:\/\/www.has-sante.fr\/upload\/docs\/application\/pdf\/ct-5303_toplexil_.pdf","DOI":"10.1016\/S1957-2557(08)71688-2"},{"issue":"1","key":"3716_CR8","first-page":"1","volume":"3","author":"A Morice","year":"2016","unstructured":"Morice A, Kardos P (2016) Comprehensive evidence-based review on European antitussives. BMJ Open Respir Res 3(1):1\u20138","journal-title":"BMJ Open Respir Res"},{"issue":"470","key":"3716_CR9","first-page":"945","volume":"42","author":"P R\u00e9daction","year":"2022","unstructured":"R\u00e9daction P (2022) Bilan 2023 des m\u00e9dicaments \u00e0 \u00e9carter\u202f: pneumologie \u2013 ORL. Rev Prescrire 42(470):945\u2013946","journal-title":"Rev Prescrire"},{"issue":"324","key":"3716_CR10","first-page":"737","volume":"30","author":"P R\u00e9daction","year":"2010","unstructured":"R\u00e9daction P (2010) Antihistaminiques H1 atropiniques et s\u00e9datifs\u202f: usages hors AMM. Rev Prescrire 30(324):737","journal-title":"Rev Prescrire"},{"issue":"190","key":"3716_CR11","doi-asserted-by":"publisher","first-page":"81","DOI":"10.56746\/EXERCER.2023.190.81","volume":"2023","author":"H Vaillant-Roussel","year":"2023","unstructured":"Vaillant-Roussel H, Blanchard C, Menini T, Charuel E, Pereira B, Naudet F et al (2023) Projet rebuild the evidence base: une m\u00e9thode d\u2019interpr\u00e9tation des essais cliniques randomis\u00e9s et de leur m\u00e9ta-analyse pour pr\u00e9senter aux patients des \u00e9valuations solides des b\u00e9n\u00e9fices et des risques. La Revue Exercer 2023(190):81\u201388","journal-title":"La Revue Exercer"},{"issue":"4","key":"3716_CR12","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.therap.2022.10.008","volume":"78","author":"R Boussageon","year":"2023","unstructured":"Boussageon R, Blanchard C, Charuel E, Menini T, Pereira B, Naudet F et al (2023) Project rebuild the evidence base (REB): a method to interpret randomised clinical trials and their meta-analysis to present solid benefit-risk assessments to patients. Therapie 78(4):353\u2013365","journal-title":"Therapie"},{"issue":"2","key":"3716_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/cl2.1230","volume":"18","author":"NR Haddaway","year":"2022","unstructured":"Haddaway NR, Page MJ, Pritchard CC, McGuinness LA (2022) PRISMA2020: an R package and Shiny app for producing PRISMA 2020-compliant flow diagrams, with interactivity for optimised digital transparency and Open Synthesis. Campbell Syst Rev 18(2):e1230","journal-title":"Campbell Syst Rev"},{"key":"3716_CR14","unstructured":"Pinho F (2019) Multicentric, randomized, open-label trial to evaluate the superiority of fixed dose combination of oxomemazine, guaifenesin and potassium iodate to guaifenesin monotherapy in acute cough treatment [Internet]. clinicaltrials.gov  [cited 2022 Oct 6]. Report No.: NCT01257243. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01257243"},{"key":"3716_CR15","unstructured":"Pinho F (2023) Comparison between oxomemazine, guaifenesin and potassium iodate versus guaifenesin monotherapy in acute cough treatment 7. Available from: https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=NCT01257243"},{"issue":"85","key":"3716_CR16","first-page":"1683","volume":"46","author":"M Alison","year":"1965","unstructured":"Alison M (1965) Therapeutic trials in children and particularly in infants of a new expectorant cough syrup with oxomemazine base. J Med Lyon 46(85):1683\u20131686","journal-title":"J Med Lyon"},{"issue":"8","key":"3716_CR17","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.jsps.2018.07.007","volume":"26","author":"EA Abdelaleem","year":"2018","unstructured":"Abdelaleem EA, Abdelwahab NS (2018) Green chromatographic method for analysis of some anti-cough drugs and their toxic impurities with comparison to conventional methods. Saudi Pharm J 26(8):1185\u20131191","journal-title":"Saudi Pharm J"},{"issue":"5","key":"3716_CR18","first-page":"577","volume":"38","author":"E Albengres","year":"1983","unstructured":"Albengres E, Guillaume JC, Chevais M (1983) A case-study of recurrent erythema multiforme exudativum with repetitive uses of tetracycline. Ectodermose pluriorificielle r\u00e9p\u00e9titive lors de traitements successifs par des t\u00e9tracyclines. A propos d\u2019un cas. Therapie 38(5):577\u20139","journal-title":"A propos d\u2019un cas. Therapie"},{"issue":"10","key":"3716_CR19","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1002\/pds.3326","volume":"21","author":"F Binder-Foucard","year":"2012","unstructured":"Binder-Foucard F, Reitzer C, Jegu J, Schweitzer B, Koehl F, Kopferschmitt J et al (2012) Use of psychotropic drugs, systemic antihistamines and medications for cough in 6-year-old children: A survey in the Bas-Rhin Region. France Pharmacoepidemiol Drug Saf 21(10):1112\u20131117","journal-title":"France Pharmacoepidemiol Drug Saf"},{"issue":"5","key":"3716_CR20","first-page":"457","volume":"57","author":"JC Pujet","year":"2002","unstructured":"Pujet JC, Keddad K, S\u00e9venier F, Jolivet-Landreau I (2002) Comparative study of two antitussive drugs in the treatment of acute dry cough of infectious origin (prospective, randomized, single blind study). Therapie 57(5):457\u2013463","journal-title":"Therapie"},{"issue":"36","key":"3716_CR21","first-page":"1221","volume":"56","author":"B von Deschwanden","year":"1967","unstructured":"von Deschwanden B, von Deschwanden P (1967) Experiences with the new cough regulator Toplexil. Praxis 56(36):1221\u20131223","journal-title":"Praxis"},{"key":"3716_CR22","unstructured":"Chapuis, Dalmais, Belpois, Meunier (1965) [Oxomemazine (new antihistaminic). Its value in general medicine]. Lyon Med 214(38):413\u20136"},{"issue":"4","key":"3716_CR23","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/j.1398-9995.2009.02325.x","volume":"65","author":"MK Church","year":"2010","unstructured":"Church MK, Maurer M, Simons FER, Bindslev-Jensen C, van Cauwenberge P, Bousquet J et al (2010) Risk of first-generation H(1)-antihistamines: a GA(2)LEN position paper. Allergy 65(4):459\u2013466","journal-title":"Allergy"},{"key":"3716_CR24","doi-asserted-by":"crossref","unstructured":"Smith SM, Schroeder K, Fahey T (2014) Over-the-counter (OTC) medications for acute cough in children and adults in community settings. Cochrane Database Syst Rev 2014(11):CD001831","DOI":"10.1002\/14651858.CD001831.pub5"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-024-03716-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-024-03716-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-024-03716-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T06:11:35Z","timestamp":1726121495000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-024-03716-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,17]]},"references-count":24,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["3716"],"URL":"https:\/\/doi.org\/10.1007\/s00228-024-03716-3","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,17]]},"assertion":[{"value":"16 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"T.B. is employed by the French Agency for the Safety of Medicines (Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9). Other authors have no competing interests to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}